Melioidosis is a disease of public health importance in South East Asia and northern Australia, caused by a Gram negative soil-dwelling bacterium, Burkholderia pseudomallei. Sporadic cases are reported from other parts of the world, including India, while detailed information is unavailable. The disease is mainly seen in the population who are in prolonged contact with soil and are diabetic. There is a close association of the disease with rainfall. The primary manifestation is pneumonia with or without septicaemia, but other organs like bone and joints, liver, spleen, lymph nodes may also be affected. Despite improvements in antibiotic therapy, melioidosis is still associated with a significant mortality attributable to severe sepsis and its complications. The accurate and practical diagnostic set up is still unavailable in many parts of India, which leads to under- or mis-diagnosis, and fatality. The disease needs more attention from the microbiologists, clinicians and researchers from India, since studies related to the pathogenesis and virulence factors, preventive measures, vaccine prospects, and better management may reduce the burden of the disease.
An account of a glanders-like disease occurring in Rangoon. J Hyg 1913;13:1-34.
An account of the discovery of a hitherto underscribed infective disease occurring among the population of Rangoon. Indian Med Gazette 1912;47:262-7.
Morphia injectors' septicaemia. Indian Med Gaz 1917;52:296-9.
Melioidosis, a new disease of the tropics. Trans Fourth Congr Far East Assoc Trop Med 1921;2:196-8.
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992;36:1251-75.
Melioidosis. Lancet 2003;361:1715-22.
Melioidosis: Epidemiology, Pathophysiology, and Management. Clin Microbiol Rev 2005;18:383-416.
The global distribution of Burkholderia pseudomallei and melioidosis: An update. Trans R Soc Trop Med Hyg 2008;102 (Suppl 1):S1-4.
Case report: Melioidosis imported from West Africa to Europe. Am J Trop Med Hyg 2011;85:282-4.
Melioidosis acquired by traveler to Nigeria. Emerg Infect Dis 2011;17:1296-8.
Chronic melioidosis: The first report of a case infected in central India. Glasgow Med J 1953;34:61-7.
Septic melioidosis following a visit to India. Schweiz Med Wochenschr 1988;188:558-64.
Melioidosis in India. Indian Pediatr 1991;28:184-8.
Melioidosis, the mimicker of maladies. Indian J Med Res 2004;119:vi-viii.
Current studies on the pathogenesis of melioidosis. Microbes Infect 1999;1:157-62.
Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol 1994;40:903-10.
Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect Immun 1998;66:1588-93.
Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect Immun 1996;64:4952-9.
The histopathology of human melioidosis. Histopathology 1995;26:51-5.
Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: A possible mechanism for cell-to-cell spreading. Infect Immun 2000;68:5377-84.
Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 1995;21:1498-500.
Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis 1999;29:813-8.
Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect Immun 1995;63:3959-65.
Detection of bacterial virulence genes by subtractive hybridization: Identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 2001;69:34-44.
Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med Microbiol Immunol (Berl)1999;188:91-7.
Melioidosis. NEJM 2012;367:1035-44.
Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J Infect Dis 1991;163:1145-8.
Tumor necrosis factor in septicemic melioidosis. J Infect Dis 1992;165:561-4.
Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60:2402-8.
Prognostic value of cytokine concentrations (tumor necrosis factor, interleukin 6 and interleukin 10) and clinical parameters in severe melioidosis. J Infect Dis 2000;181:621-5.
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis. Infect Immun 2000;68:3888-93.
Soluble granzymes are released during human endotoxemia and in patients with severe infection due to Gram-negative bacteria. J Infect Dis 2000;182:206-13.
The humoral immune response in melioidosis patients during therapy. Infection 2003;31:24-30.
Emergence of Burkholderia pseudomallei and pandrug-resistant non-fermenters from southern Karnataka, India. Trans Royal Soc Trop Med Hyg 2008;102:S12-7.
Emerging clinico-epidemiological trends in melioidosis: Analysis of 95 cases from western coastal India. Int J Infec Dis 2012;16:e491-7.
Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am J Trop Med Hyg 1997;57:96-9.
Melioidosis in the Americas. Am J Trop Med Hyg 2006;75:947-54.
The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol 1990;33:121-6.
An improved screening for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979;11:293-7.
Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol 1989;42:645-8.
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol 1996;45:408-12.
Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 2005;43:2201-6.
Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002;40:4625-7.
Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol 1999;37:225-8.
Short report: A rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia thailandensis. Am J Trop Med Hyg 2002;66:759-61.
Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol 2000;49:1075-8.
Rapid identification of Burkholderia pseudomallei in blood cultures by latex agglutination using lipopolysaccharide-specific monoclonal antibody. Am J Trop Med Hyg 1999;61:658-62.
Rapid identification of Burkholderia pseudomallei in blood culture supernatants by a coagglutination assay. Clin Microbiol Infect 2005;11:930-3.
Immunofluorescence microscopy for the rapid diagnosis of melioidosis. J Clin Pathol 1994;47:377-9.
Rapid immunofluorescence microscopy for diagnosis of melioidosis. Clin Diagn Lab Immunol 2005;12:555-6.
Enzyme-linked immunosorbent assay for the diagnosis of melioidosis: Better than we thought. Clin Infect Dis 2011;52:1024-8.
Evaluation of Immunoglobulin M (IgM) and IgG Rapid Cassette Test Kits for Diagnosis of Melioidosis in an Area of Endemicity. J Clin Microbiol 2004;42:3435-7.
Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients. J Med Microbiol 2001;50:55-61.
Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 2007;77:814-7.
Evaluation of PCR for diagnosis of melioidosis. J Clin Microbiol 1998;36:1039-41.
Short report: Application of a polymerase chain reaction to detect Burkholderia pseudomallei in clinical specimens from patients with suspected melioidosis. Am J Trop Med Hyg 2005;73:1162-4.